Biliary Sphincterotomy Alone versus Biliary Stent with or without Biliary Sphincterotomy for the Management of Post-Cholecystectomy Bile Leak: A Systematic Review and Meta-Analysis.


Journal

Digestive diseases (Basel, Switzerland)
ISSN: 1421-9875
Titre abrégé: Dig Dis
Pays: Switzerland
ID NLM: 8701186

Informations de publication

Date de publication:
2022
Historique:
received: 31 07 2020
accepted: 31 01 2022
pubmed: 8 2 2022
medline: 19 11 2022
entrez: 7 2 2022
Statut: ppublish

Résumé

Endoscopic therapy with endoscopic retrograde cholangiopancreatography is considered the first-line treatment in the management of post-cholecystectomy bile leak (PCBL). Currently, there is no consensus on the most effective endoscopic intervention for PCBL. Hence, we performed a systematic review and meta-analysis to compare the effectiveness and safety of the two interventional groups (biliary sphincterotomy [BS] alone vs. biliary stent ± BS) in management of PCBL. We conducted a comprehensive search of multiple electronic databases and conference proceedings (from inception through January 2021). The primary outcome was to compare the pooled rate of clinical success between the 2 groups. The secondary outcome was to estimate the pooled rate of adverse events. The pooled rate of clinical success with BS alone (5 studies, 299 patients) was 88% (95% confidence interval (CI): 84-92%, I2: 0%) and for biliary stent ± BS (5 studies, 864 patients) was 97% (CI: 93-100%, I2: 79%). The rate of clinical success in biliary stent ± BS group was significantly higher than BS alone group (OR: 3.91 95% CI: 2.29-6.69, p < 0.001, I2: 13%). The rate of adverse events was numerically lower in biliary stent ± BS group compared to BS alone (3 studies; OR: 0.65 95% CI: 0.41-1.03, p = 0.07) without statistical significance. Low heterogeneity was noted in the analysis. Biliary stent ± BS is more effective in endoscopic management of PCBL compared to BS alone. This may be related to inter-endoscopist variation in completeness of sphincterotomy and post-sphincterotomy edema, which can influence the preferential trans-papillary flow of bile.

Sections du résumé

BACKGROUND BACKGROUND
Endoscopic therapy with endoscopic retrograde cholangiopancreatography is considered the first-line treatment in the management of post-cholecystectomy bile leak (PCBL). Currently, there is no consensus on the most effective endoscopic intervention for PCBL. Hence, we performed a systematic review and meta-analysis to compare the effectiveness and safety of the two interventional groups (biliary sphincterotomy [BS] alone vs. biliary stent ± BS) in management of PCBL.
METHODS METHODS
We conducted a comprehensive search of multiple electronic databases and conference proceedings (from inception through January 2021). The primary outcome was to compare the pooled rate of clinical success between the 2 groups. The secondary outcome was to estimate the pooled rate of adverse events.
RESULTS RESULTS
The pooled rate of clinical success with BS alone (5 studies, 299 patients) was 88% (95% confidence interval (CI): 84-92%, I2: 0%) and for biliary stent ± BS (5 studies, 864 patients) was 97% (CI: 93-100%, I2: 79%). The rate of clinical success in biliary stent ± BS group was significantly higher than BS alone group (OR: 3.91 95% CI: 2.29-6.69, p < 0.001, I2: 13%). The rate of adverse events was numerically lower in biliary stent ± BS group compared to BS alone (3 studies; OR: 0.65 95% CI: 0.41-1.03, p = 0.07) without statistical significance. Low heterogeneity was noted in the analysis.
CONCLUSIONS CONCLUSIONS
Biliary stent ± BS is more effective in endoscopic management of PCBL compared to BS alone. This may be related to inter-endoscopist variation in completeness of sphincterotomy and post-sphincterotomy edema, which can influence the preferential trans-papillary flow of bile.

Identifiants

pubmed: 35130543
pii: 000522328
doi: 10.1159/000522328
doi:

Types de publication

Systematic Review Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

810-815

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Navroop Nagra (N)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.

Jagpal Singh Klair (JS)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA, klairjagpals@gmail.com.

Mahendran Jayaraj (M)

Division of Gastroenterology and Hepatology, University of Nevada School of Medicine, Las Vegas, Nevada, USA.

Arvind R Murali (AR)

Division of Gastroenterology and Hepatology, University of Iowa Hospitals and Clinics, Iowa, Iowa, USA.

Dhruv Singh (D)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Joanna Law (J)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.

Michael Larsen (M)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.

Shayan Irani (S)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.

Richard Kozarek (R)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.

Andrew Ross (A)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.

Rajesh Krishnamoorthi (R)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH